title: Assessing new health technologies: lessons to be learned from drugs.
abstract: Balancing the interests of producers, consumers and purchasers (governments) increases the complexity of evidence-based evaluation of non-drug health technologies.
authors.affiliation: Discipline of Clinical Pharmacology, School of Population Health Sciences, Faculty of Medicine and Health Sciences, University of Newcastle, NSW. mddah@mail.newcastle.edu.au
authors.forename: D A
authors.initials: DA
authors.lastname: Henry
authors.forename: S R
authors.initials: SR
authors.lastname: Hill
mesh_terms: D001315:Australia; D003362:Cost-Benefit Analysis; D004341:Drug Evaluation; D004364:Pharmaceutical Preparations / Q000191:economics; D013673:Technology Assessment, Biomedical / Q000191:economics / Q000379:methods*; D013810:Therapeutic Equivalency
chemical_list: D004364:Pharmaceutical Preparations